Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1998 1
2006 3
2007 1
2009 1
2010 1
2012 3
2013 1
2016 1
2017 1
2018 1
2019 2
2020 1
2021 1
2022 2
2023 1
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.
Thoms JAI, Yan F, Hampton HR, Davidson S, Joshi S, Saw J, Sarowar CH, Lim XY, Nunez AC, Kakadia PM, Bhuyan GS, Zou X, Nguyen M, Ghodousi ES, Koch FC, Vafaee F, Thompson IR, Karimi MM, Pickford R, Raftery MJ, Hough S, Buckland G, Bailey M, Ghodke Y, Absar N, Vaughan L, Pasalic L, Fong CY, Kenealy M, Hiwase DK, Stoddart RI, Mohammed S, Lee L, Passam FH, Larsen SR, Spring KJ, Skarratt KK, Rebeiro P, Presgrave P, Stevenson WS, Ling S, Tiley C, Fuller SJ, Roncolato F, Enjeti AK, Hoenemann D, Lemech C, Jolly CJ, Bohlander SK, Curtis DJ, Wong JWH, Unnikrishnan A, Hertzberg M, Olivier J, Polizzotto MN, Pimanda JE. Thoms JAI, et al. Among authors: kenealy m. Nat Commun. 2025 May 13;16(1):4451. doi: 10.1038/s41467-025-59796-x. Nat Commun. 2025. PMID: 40360497 Free PMC article. Clinical Trial.
Immunosuppression-Associated Peripheral T-Cell Lymphoma.
Cliff ERS, Kenealy M. Cliff ERS, et al. Among authors: kenealy m. N Engl J Med. 2026 Jun 18;394(23):2356. doi: 10.1056/NEJMicm2501877. Epub 2026 Jun 13. N Engl J Med. 2026. PMID: 42294861 No abstract available.
Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.
Horvath N, Spencer A, Kenealy M, Joshua D, Campbell PJ, Lee JJ, Hou J, Qiu L, Kalff A, Khong T, Londhe A, Siggins S, van Kooten Losio M, Eisbacher M, Prince HM. Horvath N, et al. Among authors: kenealy m. Leuk Lymphoma. 2019 Sep;60(9):2122-2133. doi: 10.1080/10428194.2019.1579322. Epub 2019 Feb 19. Leuk Lymphoma. 2019. PMID: 30777794 Clinical Trial.
Treatment of chronic myelomonocytic leukemia with azacitidine.
Wong E, Seymour JF, Kenealy M, Westerman D, Herbert K, Dickinson M. Wong E, et al. Among authors: kenealy m. Leuk Lymphoma. 2013 Apr;54(4):878-80. doi: 10.3109/10428194.2012.730615. Epub 2012 Oct 5. Leuk Lymphoma. 2013. PMID: 22988826 No abstract available.
Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia.
Kenealy M, Hertzberg M, Benson W, Taylor K, Cunningham I, Stevenson W, Hiwase D, Eek R, Zantomio D, Jong S, Wall M, Blombery P, Gerber T, Debrincat M, Zannino D, Seymour JF. Kenealy M, et al. Haematologica. 2019 Apr;104(4):700-709. doi: 10.3324/haematol.2018.201152. Epub 2018 Dec 13. Haematologica. 2019. PMID: 30545923 Free PMC article. Clinical Trial.
20 results